EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Predictors of Venous Thromboembolism in Patients with Advanced Common Solid Cancers

Isaac E Hall, Martin S Andersen, Harlan M Krumholz, Cary P Gross

Journal of Cancer Epidemiology · 2009

DOI: 10.1155/2009/182521 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Epidemiology, 2009. Verfasst von Isaac E Hall und 3 weiteren Autor:innen. Beteiligte Einrichtung: Sections of General Internal Medicine, Primary Care Center, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208025, New Haven, CT 0652…. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: NIA NIH HHS, Beeson Career Development Award.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is uncertainty about risk heterogeneity for venous thromboembolism (VTE) in older patients with advanced cancer and whether patients can be stratified according to VTE risk. We performed a retrospective cohort study of the linked Medicare-Surveillance, Epidemiology, and End Results cancer registry in older patients with advanced cancer of lung, breast, colon, prostate, or pancreas diagnosed between 1995–1999. We used survival analysis with demographics, comorbidities, and tumor characteristics/treatment as independent variables. Outcome was VTE diagnosed at least one month after cancer diagnosis. VTE rate was highest in the first year (3.4%). Compared to prostate cancer (1.4 VTEs/100 person-years), there was marked variability in VTE risk (hazard ratio (HR) for male-colon cancer 3.73 (95% CI 2.1–6.62), female-colon cancer HR 6.6 (3.83–11.38), up to female-pancreas cancer HR 21.57 (12.21–38.09). Stage IV cancer and chemotherapy resulted in higher risk (HRs 1.75 (1.44–2.12) and 1.31 (1.0–1.57), resp.). Stratifying the cohort by cancer type and stage using recursive partitioning analysis yielded five groups of VTE rates (nonlocalized prostate cancer 1.4 VTEs/100 person-years, to nonlocalized pancreatic cancer 17.4 VTEs/100 patient-years). In a high-risk population with advanced cancer, substantial variability in VTE risk exists, with notable differences according to cancer type and stage.

Autor:innen und Institutionen

  • Sections of General Internal Medicine, Primary Care Center, Yale University School of Medicine, 333 Cedar Street, P.O. Box 208025, New Haven, CT 06520, USA.

Förderung

  • NIA NIH HHS
  • Beeson Career Development Award

Zitieren

APA

Hall, I. E., Andersen, M. S., Krumholz, H. M., & Gross, C. P. (2009). Predictors of Venous Thromboembolism in Patients with Advanced Common Solid Cancers. Journal of Cancer Epidemiology. https://doi.org/10.1155/2009/182521

Vancouver

Hall IE, Andersen MS, Krumholz HM, Gross CP. Predictors of Venous Thromboembolism in Patients with Advanced Common Solid Cancers. Journal of Cancer Epidemiology. 2009. doi:10.1155/2009/182521

BibTeX
@article{Hall2009,
  author = {Hall, Isaac E and Andersen, Martin S and Krumholz, Harlan M and Gross, Cary P},
  title = {Predictors of Venous Thromboembolism in Patients with Advanced Common Solid Cancers},
  journal = {Journal of Cancer Epidemiology},
  year = {2009},
  doi = {10.1155/2009/182521}
}
Kostenlos starten →